Good morning, and welcome to Kala Pharmaceuticals First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, a ...
For the first quarter of 2019, we reported net product revenue of $1.4 million. Kala recognizes revenue when products are delivered to distributors. Our net revenue in Q1includes some initial stocking ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary ...
Good morning. And welcome to Kala Pharmaceuticals first quarter 2019 earnings conference call. At this time, all participants are in a listen-only mode. Following the management's prepared remarks, a ...
Good morning and welcome to Kala Pharmaceutical's Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management prepared remarks, a Q&A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results